Compare Arkham (ARKM) vs Injective (INJ) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Arkham vs Injective — how do they compare? Arkham trades at Rp2,007 (market cap Rp450,32M, Rp516,07M 24h volume), while Injective trades at Rp83,895 (market cap Rp8,37T, Rp1,26T 24h volume). The key difference: Injective is far larger — about 18586.8× Arkham's market cap, and Arkham's supply is capped (225,1M / 1B ARKM (23%)) while Injective's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Arkham for 49 Days and Injective for 36 Days on average.
| ARKM | INJ | |
|---|---|---|
Market Cap | Rp450,32M | Rp8,37T |
Volume (24h) | Rp516,07M | Rp1,26T |
Circulating Supply | 225,1M / 1B ARKM (23%) | 100M INJ |
Typical Hold Time | 49 Days | 36 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKM is currently trading at Rp1,971 with a bearish technical signal, showing selling pressure across moving averages while oscillators remain neutral. The token trades below the pivot point of Rp2,048 with immediate support at Rp1,951. With only 23% of the maximum 1 million token supply in circulation and an average hold time of 49 days, the asset shows limited distribution but stable holding patterns among current investors.
The overall outlook remains cautious due to strong bearish technical signals and limited fundamental developments. Key opportunities include potential price stabilization near support levels, while major risks involve low liquidity with Rp453.71M market cap and the absence of recent ecosystem updates that could drive adoption.
INJ is trading at Rp83,360 with a market cap of Rp8.39T, showing neutral technical signals overall. The asset is currently positioned between key support at Rp82,799 and resistance at Rp86,949, with mixed moving average signals but neutral oscillators. Recent network activity shows an average hold time of 36 days, indicating moderate holding behavior among investors.
Outlook remains cautiously neutral with potential for movement toward resistance levels. Key opportunities include protocol ecosystem growth, while risks involve typical crypto volatility and regulatory uncertainty. Investors should monitor volume patterns and network adoption metrics for directional cues.
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Arkham
Arkham is a blockchain analysis platform that uses artificial intelligence to deanonymize the blockchain and on-chain data. Arkham’s platform can be used for various purposes, such as tracking stolen funds, identifying fraudsters, verifying counterparties, auditing transactions, investigating hacks, and more. Arkham claims its platform can help combat the proliferation of crypto crimes and scams by incentivizing on-chain research.
Read more on ARKM →About Injective
Injective enables access to unlimited DeFi markets. Users can create any financial market on Injective's fast, cross-chain, zero gas fee, secure, and fully decentralized exchange protocol. The trading infrastructure of Injective is supported entirely by a central limit order book that integrates the user-friendly interface and speed of centralized exchanges with the transparency of decentralized exchanges. Native token INJ is a scarce asset that used for governance, exchange value capture, liquidity mining, and staking.
Read more on INJ →
